Palliative locoregional therapy for hilar cholangiocarcinoma: Photodynamic therapy and brachytherapy;Palliative lokoregionäre Therapie des Hilären Gallengangskarzinoms: Photodynamische Therapie und Brachytherapie

Zentralblatt fur Chirurgie

Volumn 132, Issue 4, 2007, Pages 336-341

  Dumoulin, F L ^a   Horst, E ^a   Sauerbruch, T ^b   Gerhardt, T ^b  

^a ST AGNES HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Brachytherapy; Cholangiocarcinoma; Klatskin tumor; Locoregional therapy; Photodynamic therapy

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BRACHYTHERAPY; COMPARATIVE STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; HEPATIC DUCT; HUMAN; INTRAHEPATIC BILE DUCT; KLATSKIN TUMOR; METHODOLOGY; MORTALITY; PALLIATIVE THERAPY; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BRACHYTHERAPY; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FOLLOW-UP STUDIES; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN'S TUMOR; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548445387     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981202     Document Type: Article

References (27)

1. Berr F. Photodynamic therapy for cholangiocarcinoma. Semin Liver Dis 2004; 24: 177-187
2. Berr F, Wiedmann M, Tannapfel A, Halm U, Kohlhaw KR, Schmidt F, Wittekind C, Hauss J, Mossner J. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000; 31: 291-298
3. Chen Y, Wang XL, Yan ZP, Cheng JM, Wang JH, Gong GQ, Qian S, Luo JJ, Liu QX. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol 2004; 10: 3506-3510
4. Curnow A, Mcllroy BW, Postle-Hacon MJ, MacRobert AJ, Bown SG. Light dose fractionation to enhance photodynamic therapy using 5-aminolevulinic acid in the normal rat colon. Photochem Photobiol 1999; 69: 71-76
5. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378
6. Dumoulin FL, Gerhardt T, Fuchs S, Scheurlen C, Neubrand M, Layer G, Sauerbruch T. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003; 57: 860-867
7. Gonzalez Gonzalez D, Gouma DJ, Rauws EA, van Gulik TM, Bosma A, Koedooder C. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol 1999; 10 (Suppl4): 215-220
8. Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am 2002; 11: 909-921
9. Hsi RA, Rosenthal DI, Glatstein E. Photodynamic therapy in the treatment of cancer: current state of the art. Drugs 1999; 57: 725-734
10. Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radit Oncol Biol Phys 1996; 34: 767-774
11. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303 -1314
12. Maier A, Anegg U, Fell B, Rehak P, Ratzenhofer B, Tomaselli F, Sankin O, Pinter H, Smolle-Juttner FM, Friehs GB. Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus. Lasers Surg Med 2000; 26: 308-315
13. McCaughan JS, Mertens BF, Cho C, Barabash RD, Payton HW. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 1991 ; 126: 111-113
14. Messmann H, Szeimies RM, Baumler W, Knuchel R, Zirngibl H, Scholmerich J, Holstege A. Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer. Endoscopy 1997; 29: 275-280
15. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991; 53: 549-553
16. Nomura M, Yamakado K, Nomoto Y, Nakatsuka A, li N, Shoji K, Takeda K. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer. Int J Oncol 2002; 20: 325-331
17. Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Muller JM, Hortnagl H, Lochs H. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536-542
18. Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mossner J, Lochs H. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003; 125: 1355-1363
19. Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 1998; 47: 58-62
20. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005; 242: 451-458 discussion 458-461
21. Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM, de Groen PC. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 2001; 53: 500-504
22. Schmidt BF. [Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Studies I to III]. Strahlenther Onkol 2000; 176: 582-583
23. Shim CS, Cheon YK, Cha SW, Bhandari S, Moon JH, Cho YD, Kim YS, Lee LS, Lee MS, Kim BS. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 2005; 37: 425-433
24. Shin HS, SeongJ, Kim WC, Lee HS, Moon SR, Lee IJ, Lee KK, Park KR, Suh CO, Kim GE. Combination of external beam irradiation and high-doserate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys 2003; 57: 105-112
25. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw Jr B, McCashland T, Sorrell M, Tempero M, Langnas A, Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002; 2: 774-779
26. Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M, Miyamoto N. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 2003; 57: 1357-1365
27. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005; 100: 2426-2430